$9.15
0.09[0.99%]
At close: Apr 26
$9.15
0[0.00%]
After Hours: 4:20PM EDT
Neumora Therapeutics
(NASDAQ:NMRA)Neumora Therapeutics Stock (NASDAQ:NMRA), Quotes and News Summary
Neumora Therapeutics Stock (NASDAQ: NMRA) stock price, news, charts, stock research, profile.
| Open | $8.940 |
| Close | $9.150 |
| Volume / Avg. | 677.291K / 547.256K |
| Day Range | 8.820 - 9.310 |
| 52 Wk Range | 8.980 - 21.000 |
| Market Cap | $1.454B |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 24 |
| Short Interest | 3.56% |
| Days to Cover | 5.11 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Neumora Therapeutics Inc.
Sector
Health Care
Industry
Pharmaceuticals
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the globa...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Neumora Therapeutics (NMRA) stock?
You can purchase shares of Neumora Therapeutics (NASDAQ: NMRA) through any online brokerage.
Who are Neumora Therapeutics's (NMRA) competitors?
Other companies in Neumora Therapeutics’s space includes: Verona Pharma (NASDAQ:VRNA), Supernus Pharmaceuticals (NASDAQ:SUPN), Tarsus Pharmaceuticals (NASDAQ:TARS), ANI Pharmaceuticals (NASDAQ:ANIP) and Axsome Therapeutics (NASDAQ:AXSM).
What is the target price for Neumora Therapeutics (NMRA) stock?
The latest price target for Neumora Therapeutics (NASDAQ: NMRA) was reported by RBC Capital on Thursday, March 28, 2024. The analyst firm set a price target for 31.00 expecting NMRA to rise to within 12 months (a possible 238.80% upside). 10 analyst firms have reported ratings in the last year.
Current Stock Price for Neumora Therapeutics (NMRA)?
The stock price for Neumora Therapeutics (NASDAQ: NMRA) is $9.15 last updated April 26, 2024 at 4:20 PM EDT.
Does Neumora Therapeutics (NMRA) pay a dividend?
There are no upcoming dividends for Neumora Therapeutics.
When is Neumora Therapeutics (NASDAQ:NMRA) reporting earnings?
Neumora Therapeutics’s Q1 earnings are confirmed for Wednesday, May 15, 2024.
Is Neumora Therapeutics (NMRA) going to split?
There is no upcoming split for Neumora Therapeutics.
What sector and industry does Neumora Therapeutics (NMRA) operate in?
Neumora Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.